Philadelphia Pharmaceuticals Company (ASE:PHIL)

Jordan flag Jordan · Delayed Price · Currency is JOD
1.590
0.00 (0.00%)
At close: May 10, 2026
Market Cap12.08M +15.8%
Revenue (ttm)9.00M +1.9%
Net Income1.04M +21.4%
EPS0.14 +21.4%
Shares Out7.50M
PE Ratio11.67
Forward PEn/a
Dividend0.07 (4.40%)
Ex-Dividend DateMar 30, 2026
Volume1,713
Average Volume398
Open1.550
Previous Closen/a
Day's Range1.550 - 1.600
52-Week Range1.360 - 1.700
Beta-0.02
RSI51.95
Earnings DateJul 28, 2026

About ASE:PHIL

Philadelphia Pharmaceuticals Company develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan. The company provides products for skin related disorders, including anti-lice and scabicides preparations, antiseptics and disinfectants, bleaching and hyperpigmentation disorders preparations, emollients and protectives, keratolytics/topical psoriasis treatment preparations, and skin healing agents, as well as agents for dermatitis; and topical acne preparation, anti... [Read more]

Industry Pharmaceutical Preparations
Founded 1993
Employees 129
Stock Exchange Amman Stock Exchange
Ticker Symbol PHIL
Full Company Profile

Financial Performance

In 2025, ASE:PHIL's revenue was 9.17 million, an increase of 4.64% compared to the previous year's 8.76 million. Earnings were 1.01 million, an increase of 22.35%.

Financial Statements